Journal ArticleOPEN ACCESS

Risk Factors for Peripheral Neuropathy Induced by Albumin-bound Paclitaxel Plus Gemcitabine Therapy in Pancreatic Cancer Patients

  • Yamamoto N
  • Hori Y
  • Takahiro R
  • et al.
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) (2019) 45(3) 127-134
DOI: 10.5649/jjphcs.45.127
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Yamamoto, N., Hori, Y., Takahiro, R., Suga, Y., Shimada, T., & Sai, Y. (2019). Risk Factors for Peripheral Neuropathy Induced by Albumin-bound Paclitaxel Plus Gemcitabine Therapy in Pancreatic Cancer Patients. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 45(3), 127–134. https://doi.org/10.5649/jjphcs.45.127

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free